Use of lomustine to treat cutaneous nonepitheliotropic lymphoma in a cat

Authors:
  • SNShinichiro Nakamura
    Shinichiro Nakamura
  • KTKimimasa Takahashi
    Kimimasa Takahashi
  • MTMasahiro Tagawa
    Masahiro Tagawa

Abstract
A 17-year-old spayed female domestic shorthair cat was referred for evaluation of severe skin lesions, including ulceration, nodule formation, erythema, and alopecia. Cutaneous nonepitheliotropic lymphoma was diagnosed histologically. There was no evidence of visceral organ involvement, but renal function was decreased. The cat was treated with lomustine (45.5 mg/m2, PO, q 21 d), and skin lesions resolved after administration of the third dose. No severe toxicoses were identified. Results suggest that lomustine may be useful for treatment of cutaneous nonepitheliotropic lymphoma in cats; however, optimal dosage, efficacy, and potential adverse effects must be determined.

This publication has 8 references indexed in Scilit: